BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35116374)

  • 1. Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis.
    Wang X; Wang S
    Transl Cancer Res; 2021 Dec; 10(12):5246-5257. PubMed ID: 35116374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer.
    Zhang K; Jiang K; Hong R; Xu F; Xia W; Qin G; Lee K; Zheng Q; Lu Q; Zhai Q; Wang S
    PeerJ; 2020; 8():e10468. PubMed ID: 33335811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray based analysis of gene regulation by mesenchymal stem cells in breast cancer.
    Zhang M; Gao CE; Li WH; Yang Y; Chang L; Dong J; Ren YX; Chen D
    Oncol Lett; 2017 Apr; 13(4):2770-2776. PubMed ID: 28454465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B; Vastrad C; Tengli A; Iliger S
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes and pathways in esophageal adenocarcinoma using bioinformatics analysis.
    He F; Ai B; Tian L
    Biomed Rep; 2018 Oct; 9(4):305-312. PubMed ID: 30233782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Key Genes Associated with Changes in the Host Response to Severe Burn Shock: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
    Fang X; Duan SF; Gong YZ; Wang F; Chen XL
    J Inflamm Res; 2020; 13():1029-1041. PubMed ID: 33293847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of adriamycin resistance genes in breast cancer based on microarray data analysis.
    Chen Y; Lin Y; Cui Z
    Transl Cancer Res; 2020 Dec; 9(12):7486-7494. PubMed ID: 35117349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
    Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
    Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
    Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
    PeerJ; 2019; 7():e7408. PubMed ID: 31392101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics Analysis Identifies Hub Genes and Molecular Pathways Involved in Sepsis-Induced Myopathy.
    Ning YL; Yang ZQ; Xian SX; Lin JZ; Lin XF; Chen WT
    Med Sci Monit; 2020 Feb; 26():e919665. PubMed ID: 32008037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
    Deng L; Gu X; Zeng T; Xu F; Dong Z; Liu C; Chao H
    Oncol Lett; 2019 Sep; 18(3):3236-3248. PubMed ID: 31452801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.